All News #Library
Biotech
Ratio Therapeutics Names Colin Hayward Chief Medical Officer
12 Mar 2026 //
PR NEWSWIRE
Ratio Therapeutics Doses Cohort in Phase 1/2 FAP Trial
16 Dec 2025 //
PR NEWSWIRE
Ratio & TerraPower Sign Actinium-225 Supply Agreement
20 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support